Testimonials

"Our pipeline consists of several candidate drugs in clinical and late preclinical development, and as a lean organization, we rely on close and effective collaborations with external partners to ensure high standards, scalability and a cost-effective development. CTC, having both scientific and operational expertise, is an ideal and highly valued partner to us. A safe and efficient advancement of candidate drugs from preclinical to initial human testing requires broad scientific knowledge, thorough operational planning and a high level of flexibility. In our collaborations, the CTC team has showed that it is possible to build in both adaptive design elements and early exploration of efficacy signals in first-in-human (FiH) protocols while maintaining a focus on trial participant safety. Effective operations and a customer-focused mindset have, together with the adaptive design elements, made the trial conduct smooth and successful. From both a scientific and operational perspective, I would highly recommend CTC as a preferred partner for FiH and other human pharmacology trials."